|
TOP NEWS
Fed. Circ. Won't Revive Corcept's Drug Patent Feud
By Elliot Weld
The Federal Circuit on Thursday declined to revive a case from Corcept Therapeutics Inc. in which it accused Teva Pharmaceuticals USA Inc. of patent infringement over its production of a generic version of the drug Korlym, saying a district judge didn't make a clear error in ruling Corcept hadn't shown any infringement.
Opinion attached |
Read full article »
| Save to favorites »
EXPERT ANALYSIS
LEGAL INDUSTRY
Roundup
UK Litigation Roundup: Here's What You Missed In London
By Max Austin
The last week in London saw the founders of Getir sue investment fund Mubadala for more than $700 million tied to alleged breaches during the company's restructuring, the Welsh Rugby Union face a claim by Swansea Council over a proposed takeover of Cardiff Rugby, and Euro Car Parks target the Competition and Markets Authority after it was fined by the watchdog. Here, Law360 looks at these and other new claims in the U.K.
Read full article »
| Save to favorites »
Roundup
GC Cheat Sheet: The Hottest Corporate News Of The Week
By Michele Gorman
Several pension funds in New York City sued AT&T, alleging the illegal exclusion of their shareholder proposal requesting a corporate diversity report from the telecom giant's corporate ballot. In the meantime, the DOJ said the Trump administration is investigating federal contractors and grant recipients for potentially engaging in discrimination, rather than for their DEI programs. These are among the stories in corporate legal news you may have missed in the past week.
Read full article »
| Save to favorites »
|